Editorial: Aducanumab for Alzheimer’s disease?
12 Jul, 2021 | 01:15h | UTCAducanumab for Alzheimer’s disease? – The BMJ
Related: FDA approvement of Alzheimer’s drug sparks controversy among doctors.
Commentary on Twitter
Our editorial for @bmj_latest on the controversial #Aducanumab approval and what it means for patients, clinicians and researchers.
With @seb_walsh, Richard Milne @ethicsWCS, Carol Brayne @CamPubHealth https://t.co/mnhh4F1gKK— Richard Merrick (@r_merrick) July 9, 2021